Developing Novel Non-Opioid Treatments for Pain: An Overview of Xenon’s Nav1.7 and Kv7 Programs | Xenon Pharmaceuticals Inc.

Developing Novel Non-Opioid Treatments for Pain: An Overview of Xenon’s Nav1.7 and Kv7 Programs

Oct 6, 2025 11:30 AM EDT

Click here for webcast

Supporting Materials

Supporting Slides - October 6th Webinar 5.6 MB

Investor inquiries

Tucker Kelly
Chief Financial Officer
investors@xenon-pharma.com

Request Information

Email alerts

Sign up here to receive email alerts from Xenon Pharmaceuticals